{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:17:59Z","timestamp":1794385079134,"version":"4.9.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xinxiang Medical University Graduate Student Research and Innovation Support Program","award":["No. YJSCX202422Y"],"award-info":[{"award-number":["No. YJSCX202422Y"]}],"id":[{"id":"https:\/\/ror.org\/038hzq450","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Joint Construction Project of Henan Medical Science and Technology Research Plan","award":["No. LHGJ20240509"],"award-info":[{"award-number":["No. LHGJ20240509"]}]},{"name":"Henan Province Young and Middle-aged Health Science and Technology Innovation Talent Project","award":["No. YXKC2021044"],"award-info":[{"award-number":["No. YXKC2021044"]}]},{"name":"Henan Province University Science and Technology Innovation Team","award":["No. 25IRTSTHN035"],"award-info":[{"award-number":["No. 25IRTSTHN035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03765-3","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T12:30:26Z","timestamp":1744029026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["CXCL2: a key player in the tumor microenvironment and inflammatory diseases"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuanhao","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caizheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiateng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"3765_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309\u201322.","journal-title":"Cancer Cell"},{"key":"3765_CR2","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","volume":"27","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Marabelle A, Eggermont A, Soria J-C, Kroemer G, Zitvogel L. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27:1482\u201392.","journal-title":"Ann Oncol"},{"key":"3765_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","volume":"10","author":"V Mollica Poeta","year":"2019","unstructured":"Mollica Poeta V, Massara M, Capucetti A, Bonecchi R. Chemokines and chemokine receptors: new targets for cancer immunotherapy. Front Immunol. 2019;10:379.","journal-title":"Front Immunol"},{"key":"3765_CR4","doi-asserted-by":"publisher","first-page":"122691","DOI":"10.1016\/j.lfs.2024.122691","volume":"348","author":"Y Bao","year":"2024","unstructured":"Bao Y, Tong C, Xiong X. CXCL3: A key player in tumor microenvironment and inflammatory diseases. Life Sci. 2024;348:122691.","journal-title":"Life Sci"},{"key":"3765_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17:559\u201372.","journal-title":"Nat Rev Immunol"},{"key":"3765_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.semcancer.2022.02.007","volume":"86","author":"S-N Jia","year":"2022","unstructured":"Jia S-N, Han Y-B, Yang R, Yang Z-C. Chemokines in colon cancer progression. Sem Cancer Biol. 2022;86:400\u20137.","journal-title":"Sem Cancer Biol"},{"key":"3765_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.molimm.2016.11.007","volume":"81","author":"N Lou","year":"2017","unstructured":"Lou N, Lennard Richard ML, Yu J, Kindy M, Zhang XK. The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2). Mol Immunol. 2017;81:59\u201366.","journal-title":"Mol Immunol"},{"key":"3765_CR8","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/cells11152313","volume":"11","author":"L Goodla","year":"2022","unstructured":"Goodla L, Xue X. The role of inflammatory mediators in colorectal cancer hepatic metastasis. Cells. 2022;11:2313.","journal-title":"Cells"},{"key":"3765_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/610950","volume":"2013","author":"A Mu\u00f1oz","year":"2013","unstructured":"Mu\u00f1oz A, Costa M. Nutritionally mediated oxidative stress and inflammation. Oxidative Med Cell Longev. 2013;2013:1\u201311.","journal-title":"Oxidative Med Cell Longev"},{"key":"3765_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.261784","volume":"110","author":"MJ Butcher","year":"2012","unstructured":"Butcher MJ, Gjurich BN, Phillips T, Galkina EV. The IL-17A\/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. Circul Res. 2012;110:675\u201387.","journal-title":"Circul Res"},{"key":"3765_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/CIRCRESAHA.116.304918","volume":"116","author":"A Anzai","year":"2015","unstructured":"Anzai A, Shimoda M, Endo J, Kohno T, Katsumata Y, Matsuhashi T, et al. Adventitial CXCL1\/G-CSF expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture. Circul Res. 2015;116:612\u201323.","journal-title":"Circul Res"},{"key":"3765_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41420-023-01524-9","volume":"9","author":"C Zhou","year":"2023","unstructured":"Zhou C, Gao Y, Ding P, Wu T, Ji G. The role of CXCL family members in different diseases. Cell Death Discov. 2023;9:212.","journal-title":"Cell Death Discov"},{"key":"3765_CR13","doi-asserted-by":"crossref","unstructured":"Williams SA, Schwarzbauer JE. A Shared Mechanism of Adhesion Modulation for Tenascin-C and Fibulin-1. Ginsberg MH, editor. MBoC. 2009;20:1141\u20139.","DOI":"10.1091\/mbc.e08-06-0621"},{"key":"3765_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1073\/pnas.86.2.612","volume":"86","author":"SD Wolpe","year":"1989","unstructured":"Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A. Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci USA. 1989;86:612\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3765_CR15","first-page":"5596","volume":"10","author":"N Iida","year":"1990","unstructured":"Iida N, Grotendorst GR. Cloning and sequencing of a new Gro transcript from activated human monocytes: expression in leukocytes and wound tissue. Mol Cell Biol. 1990;10:5596\u20139.","journal-title":"Mol Cell Biol"},{"key":"3765_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.molimm.2003.07.001","volume":"40","author":"D-S Kim","year":"2003","unstructured":"Kim D-S, Ho Han J, Kwon H-J. NF-\u03baB and c-Jun-dependent regulation of macrophage inflammatory protein-2 gene expression in response to lipopolysaccharide in RAW 264.7 cells. Mol Immunol. 2003;40:633\u201343.","journal-title":"Mol Immunol"},{"key":"3765_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.immuni.2018.09.018","volume":"49","author":"T Girbl","year":"2018","unstructured":"Girbl T, Lenn T, Perez L, Rolas L, Barkaway A, Thiriot A, et al. Distinct compartmentalization of the chemokines CXCL1 and CXCL2 and the atypical receptor ACKR1 determine discrete stages of neutrophil diapedesis. Immunity. 2018;49:1062\u2013e10766.","journal-title":"Immunity"},{"key":"3765_CR18","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4155\/fmc.12.48","volume":"4","author":"V Vinader","year":"2012","unstructured":"Vinader V, Afarinkia K. The emerging role of CXC chemokines and their receptors in cancer. Future Med Chem. 2012;4:853\u201367.","journal-title":"Future Med Chem"},{"key":"3765_CR19","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.1016\/S0021-9258(18)98935-0","volume":"266","author":"PM Murphy","year":"1991","unstructured":"Murphy PM, McDermott D. Functional expression of the human formyl peptide receptor in xenopus oocytes requires a complementary human factor. J Biol Chem. 1991;266:12560\u20137.","journal-title":"J Biol Chem"},{"key":"3765_CR20","doi-asserted-by":"publisher","first-page":"26381","DOI":"10.1016\/S0021-9258(18)47205-5","volume":"269","author":"SK Ahuja","year":"1994","unstructured":"Ahuja SK, Shetty A, Tiffany HL, Murphy PM. Comparison of the genomic organization and promoter function for human interleukin-8 receptors A and B. J Biol Chem. 1994;269:26381\u20139.","journal-title":"J Biol Chem"},{"key":"3765_CR21","doi-asserted-by":"publisher","first-page":"204062072095858","DOI":"10.1177\/2040620720958586","volume":"11","author":"W Tang","year":"2020","unstructured":"Tang W, Li Z, Li X, Huo Z. High CXCR2 expression predicts poor prognosis in adult patients with acute myeloid leukemia. Therapeutic Adv Hematol. 2020;11:204062072095858.","journal-title":"Therapeutic Adv Hematol"},{"key":"3765_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2017.09.030","volume":"412","author":"H Xu","year":"2018","unstructured":"Xu H, Lin F, Wang Z, Yang L, Meng J, Ou Z, et al. CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2. Cancer Lett. 2018;412:69\u201380.","journal-title":"Cancer Lett"},{"key":"3765_CR23","doi-asserted-by":"publisher","first-page":"28442","DOI":"10.18632\/oncotarget.16086","volume":"8","author":"J Zhao","year":"2017","unstructured":"Zhao J, Ou B, Feng H, Wang P, Yin S, Zhu C, et al. Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer. Oncotarget. 2017;8:28442\u201354.","journal-title":"Oncotarget"},{"key":"3765_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s12032-013-0809-z","volume":"31","author":"P Sui","year":"2014","unstructured":"Sui P, Hu P, Zhang T, Zhang X, Liu Q, Du J. High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma. Med Oncol. 2014;31:809.","journal-title":"Med Oncol"},{"key":"3765_CR25","doi-asserted-by":"publisher","first-page":"e0178635","DOI":"10.1371\/journal.pone.0178635","volume":"12","author":"H Kasashima","year":"2017","unstructured":"Kasashima H, Yashiro M, Nakamae H, Masuda G, Kinoshita H, Morisaki T et al. A Ahmad editor 2017 Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma. PLoS ONE 12 e0178635.","journal-title":"PLoS ONE"},{"key":"3765_CR26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1186\/s12885-015-1793-9","volume":"15","author":"Z Wang","year":"2015","unstructured":"Wang Z, Liu H, Shen Z, Wang X, Zhang H, Qin J, et al. The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients. BMC Cancer. 2015;15:766.","journal-title":"BMC Cancer"},{"key":"3765_CR27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.surg.2013.12.037","volume":"155","author":"H Sueoka","year":"2014","unstructured":"Sueoka H, Hirano T, Uda Y, Iimuro Y, Yamanaka J, Fujimoto J. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma. Surgery. 2014;155:640\u20139.","journal-title":"Surgery"},{"key":"3765_CR28","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1007\/s12032-011-0152-1","volume":"29","author":"L Han","year":"2012","unstructured":"Han L, Jiang B, Wu H, Wang X, Tang X, Huang J, et al. High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma. Med Oncol. 2012;29:2466\u201372.","journal-title":"Med Oncol"},{"key":"3765_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/0008-5472.CAN-12-0263","volume":"73","author":"P Saintigny","year":"2013","unstructured":"Saintigny P, Massarelli E, Lin S, Ahn Y-H, Chen Y, Goswami S, et al. CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Res. 2013;73:571\u201382.","journal-title":"Cancer Res"},{"key":"3765_CR30","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1080\/15384101.2019.1689471","volume":"18","author":"L Wei","year":"2019","unstructured":"Wei L, Liu Y, Ma Y, Ding C, Zhang H, Lu Z, et al. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2\/STAT3 pathway in non-small cell lung cancer. Cell Cycle. 2019;18:3456\u201371.","journal-title":"Cell Cycle"},{"key":"3765_CR31","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-10-0483","volume":"16","author":"G Yang","year":"2010","unstructured":"Yang G, Rosen DG, Liu G, Yang F, Guo X, Xiao X, et al. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res. 2010;16:3875\u201386.","journal-title":"Clin Cancer Res"},{"key":"3765_CR32","doi-asserted-by":"publisher","first-page":"13405","DOI":"10.18632\/aging.203074","volume":"13","author":"TB Henriques","year":"2021","unstructured":"Henriques TB, Dos Santos DZ, Dos Santos Guimar\u00e3es I, Tessarollo NG, Lyra-Junior PCM, Mesquita P, et al. Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment. Aging. 2021;13:13405\u201320.","journal-title":"Aging"},{"key":"3765_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.bbi.2019.05.031","volume":"80","author":"W Jiang","year":"2019","unstructured":"Jiang W, Li Y, Li Z-Z, Sun J, Li J-W, Wei W, et al. Chronic restraint stress promotes hepatocellular carcinoma growth by mobilizing Splenic myeloid cells through activating \u03b2-adrenergic signaling. Brain Behav Immun. 2019;80:825\u201338.","journal-title":"Brain Behav Immun"},{"key":"3765_CR34","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/s41388-023-02824-1","volume":"42","author":"X Liu","year":"2023","unstructured":"Liu X, Tian F, Cui J, Gong L, Xiang L, Fan B, et al. CUL4B functions as a tumor suppressor in KRAS-driven lung tumors by inhibiting the recruitment of myeloid-derived suppressor cells. Oncogene. 2023;42:3113\u201326.","journal-title":"Oncogene"},{"key":"3765_CR35","doi-asserted-by":"publisher","first-page":"D891","DOI":"10.1093\/nar\/gkad1049","volume":"52","author":"PW Harrison","year":"2024","unstructured":"Harrison PW, Amode MR, Austine-Orimoloye O, Azov AG, Barba M, Barnes I, et al. Ensembl 2024. Nucleic Acids Res. 2024;52:D891\u20139.","journal-title":"Nucleic Acids Res"},{"key":"3765_CR36","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"A Bateman","year":"2023","unstructured":"The UniProt Consortium, Bateman A, Martin M-J, Orchard S, Magrane M, Ahmad S, et al. UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res. 2023;51:D523\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3765_CR37","doi-asserted-by":"publisher","first-page":"W420","DOI":"10.1093\/nar\/gkac373","volume":"50","author":"Y Xie","year":"2022","unstructured":"Xie Y, Li H, Luo X, Li H, Gao Q, Zhang L, et al. IBS 2.0: an upgraded illustrator for the visualization of biological sequences. Nucleic Acids Res. 2022;50:W420\u20136.","journal-title":"Nucleic Acids Res"},{"key":"3765_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with alphafold 3. Nature. 2024;630:493\u2013500.","journal-title":"Nature"},{"key":"3765_CR39","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/kjm2.12261","volume":"36","author":"Y Ma","year":"2020","unstructured":"Ma Y, Zhao H, Shi Y, Cheng M. MicroRNA -532\u20105p is a prognostic marker and inhibits the aggressive phenotypes of osteosarcoma through targeting CXCL2. Kaohsiung J Med Scie. 2020;36:885\u201394.","journal-title":"Kaohsiung J Med Scie"},{"key":"3765_CR40","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1152\/ajpendo.00347.2013","volume":"306","author":"SJ Burke","year":"2014","unstructured":"Burke SJ, Lu D, Sparer TE, Masi T, Goff MR, Karlstad MD, et al. NF-\u03baB and STAT1 control CXCL1 and CXCL2 gene transcription. Am J Physiology-Endocrinology Metabolism. 2014;306:E131\u201349.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"3765_CR41","doi-asserted-by":"publisher","first-page":"886520","DOI":"10.3389\/fimmu-13-886520","volume":"13","author":"B Heinrich","year":"2022","unstructured":"Heinrich B, Korangy F. Plasticity of innate lymphoid cells in cancer. Front Immunol. 2022;13:886520.","journal-title":"Front Immunol"},{"key":"3765_CR42","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/hep.31855","volume":"74","author":"X Xu","year":"2021","unstructured":"Xu X, Ye L, Zhang Q, Shen H, Li S, Zhang X, et al. Group-2 innate lymphoid cells promote HCC progression through CXCL2\u2010Neutrophil\u2010Induced immunosuppression. Hepatology. 2021;74:2526\u201343.","journal-title":"Hepatology"},{"key":"3765_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41420-023-01418-w","volume":"9","author":"Z Zeng","year":"2023","unstructured":"Zeng Z, Li Z, Xue J, Xue H, Liu Z, Zhang W, et al. KDM4C Silencing inhibits cell migration and enhances radiosensitivity by inducing CXCL2 transcription in hepatocellular carcinoma. Cell Death Discov. 2023;9:137.","journal-title":"Cell Death Discov"},{"key":"3765_CR44","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.apsb.2023.01.020","volume":"13","author":"Y Chan","year":"2023","unstructured":"Chan Y, Tan H, Lu Y, Zhang C, Cheng C, Wu J, et al. Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Acta Pharm Sinica B. 2023;13:1554\u201367.","journal-title":"Acta Pharm Sinica B"},{"key":"3765_CR45","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.18632\/aging.204922","volume":"15","author":"J Shen","year":"2023","unstructured":"Shen J, Wang R, Chen Y, Fang Z, Tang J, Yao J, et al. Prognostic significance and mechanisms of CXCL genes in clear cell renal cell carcinoma. Aging. 2023;15:7974\u201396.","journal-title":"Aging"},{"key":"3765_CR46","doi-asserted-by":"publisher","first-page":"e31096","DOI":"10.1097\/MD.0000000000031096","volume":"101","author":"J Zhang","year":"2022","unstructured":"Zhang J, Hou W, Zuo J, Huang Z, Ding X, Bu X. CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma. Medicine. 2022;101:e31096.","journal-title":"Medicine"},{"key":"3765_CR47","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/carcin\/bgp043","volume":"30","author":"I Kogan-Sakin","year":"2009","unstructured":"Kogan-Sakin I, Cohen M, Paland N, Madar S, Solomon H, Molchadsky A, et al. Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis. 2009;30:698\u2013705.","journal-title":"Carcinogenesis"},{"key":"3765_CR48","doi-asserted-by":"publisher","first-page":"5038172","DOI":"10.1155\/2018\/5038172","volume":"2018","author":"Z Jin","year":"2018","unstructured":"Jin Z, Yao J, Xie N, Cai L, Qi S, Zhang Z, et al. Melittin constrains the expression of identified key genes associated with bladder cancer. J Immunol Res. 2018;2018:5038172.","journal-title":"J Immunol Res"},{"key":"3765_CR49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/1744666X.2024.2305808","volume":"20","author":"H-Z Ji","year":"2024","unstructured":"Ji H-Z, Liu B, Ren M, Li S, Zheng J-F, Liu T-Y, et al. The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer. Expert Rev Clin Immunol. 2024;20:559\u201369.","journal-title":"Expert Rev Clin Immunol"},{"key":"3765_CR50","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.7150\/ijbs.65227","volume":"18","author":"C Zhou","year":"2022","unstructured":"Zhou C, He X, Tong C, Li H, Xie C, Wu Y, et al. Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF\/CXCLs positive feedback loop. Int J Biol Sci. 2022;18:1363\u201380.","journal-title":"Int J Biol Sci"},{"key":"3765_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/dna.2009.1006","volume":"29","author":"D-A Tsao","year":"2010","unstructured":"Tsao D-A, Chang H-J, Lin C-Y, Hsiung S-K, Huang S-E, Ho S-Y, et al. Gene expression profiles for predicting the efficacy of the anticancer drug 5-fluorouracil in breast cancer. DNA Cell Biol. 2010;29:285\u201393.","journal-title":"DNA Cell Biol"},{"key":"3765_CR52","first-page":"1","volume":"2020","author":"K Liu","year":"2020","unstructured":"Liu K, Lai M, Wang S, Zheng K, Xie S, Wang X. Construction of a CXC Chemokine-Based prediction model for the prognosis of colon cancer. Biomed Res Int. 2020;2020:1\u201312.","journal-title":"Biomed Res Int"},{"key":"3765_CR53","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3892\/ol.2022.13468","volume":"24","author":"X Luo","year":"2022","unstructured":"Luo X, Tai J, Zhao Y, Zhao P, Sun D, Wang L. Associations of C-X-C motif chemokine ligands 1\/2\/8\/13\/14 with clinicopathological features and survival profile in patients with colorectal cancer. Oncol Lett. 2022;24:348.","journal-title":"Oncol Lett"},{"key":"3765_CR54","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10585-021-10103-0","volume":"38","author":"M Lepsenyi","year":"2021","unstructured":"Lepsenyi M, Algethami N, Al-Haidari AA, Algaber A, Syk I, Rahman M, et al. CXCL2-CXCR2 axis mediates \u0391V integrin-dependent peritoneal metastasis of colon cancer cells. Clin Exp Metastasis. 2021;38:401\u201310.","journal-title":"Clin Exp Metastasis"},{"key":"3765_CR55","doi-asserted-by":"publisher","first-page":"11822","DOI":"10.1002\/jcp.27891","volume":"234","author":"M Chen","year":"2019","unstructured":"Chen M, Baskaran R, Lee N, Hsu H, Ho T, Tu C, et al. CXCL2\/CXCR2 axis induces cancer stem cell characteristics in CPT-11\u2010resistant LoVo colon cancer cells via G\u03b1i\u20102 and G\u03b1q\/11. J Cell Physiol. 2019;234:11822\u201334.","journal-title":"J Cell Physiol"},{"key":"3765_CR56","doi-asserted-by":"publisher","first-page":"1407995","DOI":"10.3389\/fimmu.2024.1407995","volume":"15","author":"TA Omran","year":"2024","unstructured":"Omran TA, Tunsj\u00f8 HS, Jahanlu D, Brackmann SA, Bemanian V, S\u00e6ther PC. Decoding immune-related gene-signatures in colorectal neoplasia. Front Immunol. 2024;15:1407995.","journal-title":"Front Immunol"},{"key":"3765_CR57","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.7150\/ijbs.66854","volume":"18","author":"Z Bao","year":"2022","unstructured":"Bao Z, Zeng W, Zhang D, Wang L, Deng X, Lai J, et al. SNAIL induces EMT and lung metastasis of tumours secreting CXCL2 to promote the invasion of M2-Type immunosuppressed macrophages in colorectal cancer. Int J Biol Sci. 2022;18:2867\u201381.","journal-title":"Int J Biol Sci"},{"key":"3765_CR58","doi-asserted-by":"crossref","unstructured":"Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Modern Pathology. 2017;30:1299\u2013311.","DOI":"10.1038\/modpathol.2017.46"},{"key":"3765_CR59","doi-asserted-by":"crossref","unstructured":"Dawson H, Galuppini F, Tr\u00e4ger P, Berger MD, Studer P, Br\u00fcgger L et al. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer. Human Pathology. 2019;85:145\u201351.","DOI":"10.1016\/j.humpath.2018.10.023"},{"key":"3765_CR60","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1097\/PAS.0000000000000504","volume":"39","author":"RP Graham","year":"2015","unstructured":"Graham RP, Vierkant RA, Tillmans LS, Wang AH, Laird PW, Weisenberger DJ, et al. Tumor budding in colorectal carcinoma: confirmation of prognostic significance and histologic cutoff in a Population-based cohort. Am J Surg Pathol. 2015;39:1340\u20136.","journal-title":"Am J Surg Pathol"},{"key":"3765_CR61","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/modpathol.2012.94","volume":"25","author":"B Mitrovic","year":"2012","unstructured":"Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R. Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol. 2012;25:1315\u201325.","journal-title":"Mod Pathol"},{"key":"3765_CR62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fmed.2020.00264","volume":"7","author":"S Guil-Luna","year":"2020","unstructured":"Guil-Luna S, Mena R, Navarrete-Sirvent C, L\u00f3pez-S\u00e1nchez LM, Khouadri K, Toledano-Fonseca M, et al. Association of tumor budding with immune evasion pathways in primary colorectal cancer and Patient-Derived xenografts. Front Med (Lausanne). 2020;7:264.","journal-title":"Front Med (Lausanne)"},{"key":"3765_CR63","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.2147\/IJGM.S352511","volume":"15","author":"K Wang","year":"2022","unstructured":"Wang K, Li R, Zhang Y, Qi W, Fang T, Yue W, et al. Prognostic significance and therapeutic target of CXC chemokines in the microenvironment of lung adenocarcinoma. Int J Gen Med. 2022;15:2283\u2013300.","journal-title":"Int J Gen Med"},{"key":"3765_CR64","doi-asserted-by":"publisher","first-page":"748","DOI":"10.21037\/tcr-20-2539","volume":"10","author":"L Gu","year":"2021","unstructured":"Gu L, Yao Y, Chen Z. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients. Transl Cancer Res. 2021;10:748\u201358.","journal-title":"Transl Cancer Res"},{"key":"3765_CR65","doi-asserted-by":"crossref","unstructured":"Inoue C, Miki Y, Saito R, Hata S, Abe J, Sato I et al. PD-L1 induction by Cancer-Associated Fibroblast-Derived factors in lung adenocarcinoma cells. Cancers (Basel). 2019;11.","DOI":"10.3390\/cancers11091257"},{"key":"3765_CR66","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/ijc.31923","volume":"144","author":"N Matsuo","year":"2019","unstructured":"Matsuo N, Azuma K, Hattori S, Ohtake J, Kawahara A, Ishii H, et al. Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti-PD-1 inhibitor. Int J Cancer. 2019;144:1170\u20139.","journal-title":"Int J Cancer"},{"key":"3765_CR67","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3892\/ol.2023.14079","volume":"26","author":"C Zhai","year":"2023","unstructured":"Zhai C, Liu B, Kan F, Zhai S, Zhang R. MicroRNA\u201327a\u20133p regulates the proliferation and chemotaxis of pulmonary macrophages in non\u2013small cell lung carcinoma tissues through CXCL2. Oncol Lett. 2023;26:492.","journal-title":"Oncol Lett"},{"key":"3765_CR68","doi-asserted-by":"crossref","unstructured":"La\u2019ah AS, Tsai P-H, Yarmishyn AA, Ching L-J, Chen C-Y, Chien Y et al. Neutrophils Recruited by NKX2-1 Suppression via Activation of CXCLs\/CXCR2 Axis Promote Lung Adenocarcinoma Progression. Adv Sci (Weinh). 2024;e2400370.","DOI":"10.21203\/rs.3.rs-3646385\/v1"},{"key":"3765_CR69","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12920-019-0482-y","volume":"12","author":"J Lu","year":"2019","unstructured":"Lu J, Xu W, Qian J, Wang S, Zhang B, Zhang L, et al. Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells. BMC Med Genomics. 2019;12:38.","journal-title":"BMC Med Genomics"},{"key":"3765_CR70","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/CCO.0b013e32833fb384","volume":"22","author":"F Andre","year":"2010","unstructured":"Andre F, Berrada N, Desmedt C. Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients. Curr Opin Oncol. 2010;22:547\u201351.","journal-title":"Curr Opin Oncol"},{"key":"3765_CR71","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell. 2005;121:335\u201348.","journal-title":"Cell"},{"key":"3765_CR72","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nm1379","volume":"12","author":"K Polyak","year":"2006","unstructured":"Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med. 2006;12:296\u2013300.","journal-title":"Nat Med"},{"key":"3765_CR73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2020.12.016","volume":"534","author":"A Dwivedi","year":"2021","unstructured":"Dwivedi A, Kiely PA, Hoey DA. Mechanically stimulated osteocytes promote the proliferation and migration of breast cancer cells via a potential CXCL1\/2 mechanism. Biochem Biophys Res Commun. 2021;534:14\u201320.","journal-title":"Biochem Biophys Res Commun"},{"key":"3765_CR74","doi-asserted-by":"crossref","unstructured":"Lai Y-W, Liu Z-W, Lin M-H, Yang C-C, Chu C-Y, Chung C-H et al. Melatonin increases Olaparib sensitivity and suppresses cancer-associated fibroblast activation via suppressing the LAMB3-CXCL2 axis in TNBC. Pharmacol Res. 2024;107429.","DOI":"10.1016\/j.phrs.2024.107429"},{"key":"3765_CR75","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, et al. Cancer-Associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71:2455\u201365.","journal-title":"Cancer Res"},{"key":"3765_CR76","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2012.05.019","volume":"324","author":"Y-Y Wang","year":"2012","unstructured":"Wang Y-Y, Lehu\u00e9d\u00e9 C, Laurent V, Dirat B, Dauvillier S, Bochet L, et al. Adipose tissue and breast epithelial cells: A dangerous dynamic duo in breast cancer. Cancer Lett. 2012;324:142\u201351.","journal-title":"Cancer Lett"},{"key":"3765_CR77","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1309\/MX6KKA1UNJ1YG8VN","volume":"130","author":"J Yamaguchi","year":"2008","unstructured":"Yamaguchi J, Ohtani H, Nakamura K, Shimokawa I, Kanematsu T. Prognostic impact of marginal adipose tissue invasion in ductal carcinoma of the breast. Am J Clin Pathol. 2008;130:382\u20138.","journal-title":"Am J Clin Pathol"},{"key":"3765_CR78","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/cells9030560","volume":"9","author":"I Rybinska","year":"2020","unstructured":"Rybinska I, Agresti R, Trapani A, Tagliabue E, Triulzi T. Adipocytes in breast cancer, the Thick and the thin. Cells. 2020;9:560.","journal-title":"Cells"},{"key":"3765_CR79","doi-asserted-by":"publisher","first-page":"665080","DOI":"10.3389\/fonc.2021.665080","volume":"11","author":"F Wang","year":"2021","unstructured":"Wang F, Yuan C, Wu H-Z, Liu B, Yang Y-F, Bioinformatics. Molecular Docking and experiments in vitro analyze the prognostic value of CXC chemokines in breast cancer. Front Oncol. 2021;11:665080.","journal-title":"Front Oncol"},{"key":"3765_CR80","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.omto.2020.12.011","volume":"20","author":"YC Pan","year":"2021","unstructured":"Pan YC, Nishikawa T, Chang CY, Tai JA, Kaneda Y. CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy. Mol Ther Oncolytics. 2021;20:175\u201386.","journal-title":"Mol Ther Oncolytics"},{"key":"3765_CR81","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1002\/cam4.843","volume":"5","author":"K-Q Han","year":"2016","unstructured":"Han K-Q, Han H, He X-Q, Wang L, Guo X-D, Zhang X-M, et al. Chemokine CXCL1 May serve as a potential molecular target for hepatocellular carcinoma. Cancer Med. 2016;5:2861\u201371.","journal-title":"Cancer Med"},{"key":"3765_CR82","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1007\/s13277-015-3334-1","volume":"36","author":"Y Li","year":"2015","unstructured":"Li Y, Wang Y, Zhang P. Clinical significance of serum expression of GRO\u03b2 in hepatocellular carcinoma. Tumour Biol. 2015;36:6445\u20139.","journal-title":"Tumour Biol"},{"key":"3765_CR83","first-page":"1065","volume":"20","author":"L Liu","year":"2019","unstructured":"Liu L, Sun H, Wu S, Tan H, Sun Y, Liu X, et al. IL\u201317A promotes CXCR2\u2013dependent angiogenesis in a mouse model of liver cancer. Mol Med Rep. 2019;20:1065\u201374.","journal-title":"Mol Med Rep"},{"key":"3765_CR84","doi-asserted-by":"publisher","first-page":"24558","DOI":"10.1038\/srep24558","volume":"6","author":"Y Lu","year":"2016","unstructured":"Lu Y, Li S, Ma L, Li Y, Zhang X, Peng Q, et al. Type conversion of secretomes in a 3D TAM2 and HCC cell co-culture system and functional importance of CXCL2 in HCC. Sci Rep. 2016;6:24558.","journal-title":"Sci Rep"},{"key":"3765_CR85","first-page":"2254","volume":"7","author":"X Song","year":"2015","unstructured":"Song X, Wang Z, Jin Y, Wang Y, Duan W. Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC. Am J Transl Res. 2015;7:2254\u201361.","journal-title":"Am J Transl Res"},{"key":"3765_CR86","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jhep.2020.05.004","volume":"73","author":"Z-P Peng","year":"2020","unstructured":"Peng Z-P, Jiang Z-Z, Guo H-F, Zhou M-M, Huang Y-F, Ning W-R, et al. Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma. J Hepatol. 2020;73:906\u201317.","journal-title":"J Hepatol"},{"key":"3765_CR87","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41467-023-37227-z","volume":"14","author":"T Wang","year":"2023","unstructured":"Wang T, Zhou Y, Zhou Z, Zhang P, Yan R, Sun L, et al. Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps. Nat Commun. 2023;14:1513.","journal-title":"Nat Commun"},{"key":"3765_CR88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12929-022-00881-4","volume":"29","author":"H-C Wang","year":"2022","unstructured":"Wang H-C, Haung L-Y, Wang C-J, Chao Y-J, Hou Y-C, Yen C-J, et al. Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against Sorafenib by activating CXCR2 signaling. J Biomed Sci. 2022;29:99.","journal-title":"J Biomed Sci"},{"key":"3765_CR89","doi-asserted-by":"crossref","unstructured":"Deng H, Kan A, Lyu N, He M, Huang X, Qiao S et al. Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma. J Immunother Cancer. 2021;9.","DOI":"10.1136\/jitc-2020-002305"},{"key":"3765_CR90","doi-asserted-by":"publisher","first-page":"e31096","DOI":"10.1097\/MD.0000000000031096","volume":"101","author":"J Zhang","year":"2022","unstructured":"Zhang J, Hou W, Zuo J, Huang Z, Ding X, Bu X. CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma. Med (Baltim). 2022;101:e31096.","journal-title":"Med (Baltim)"},{"key":"3765_CR91","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1016\/j.ajpath.2016.07.024","volume":"186","author":"H Kasashima","year":"2016","unstructured":"Kasashima H, Yashiro M, Nakamae H, Kitayama K, Masuda G, Kinoshita H, et al. CXCL1\u2013Chemokine (C-X-C Motif) receptor 2 signaling stimulates the recruitment of bone Marrow\u2013Derived mesenchymal cells into Diffuse-Type gastric cancer stroma. Am J Pathol. 2016;186:3028\u201339.","journal-title":"Am J Pathol"},{"key":"3765_CR92","first-page":"484","volume":"13","author":"X Chen","year":"2020","unstructured":"Chen X, Chen R, Jin R, Huang Z. The role of CXCL chemokine family in the development and progression of gastric cancer. Int J Clin Exp Pathol. 2020;13:484\u201392.","journal-title":"Int J Clin Exp Pathol"},{"key":"3765_CR93","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41416-020-0898-3","volume":"123","author":"M Natsume","year":"2020","unstructured":"Natsume M, Shimura T, Iwasaki H, Okuda Y, Hayashi K, Takahashi S, et al. Omental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2-VEGFA axis. Br J Cancer. 2020;123:459\u201370.","journal-title":"Br J Cancer"},{"key":"3765_CR94","first-page":"68","volume":"12","author":"S Saxena","year":"2022","unstructured":"Saxena S, Molczyk C, Purohit A, Ehrhorn E, Goel P, Prajapati DR, et al. Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma. Am J Cancer Res. 2022;12:68\u201390.","journal-title":"Am J Cancer Res"},{"key":"3765_CR95","doi-asserted-by":"publisher","first-page":"e24125","DOI":"10.1097\/MD.0000000000024125","volume":"100","author":"F Zhang","year":"2021","unstructured":"Zhang F, Jiang J, Xu B, Xu Y, Wu C. Over-expression of CXCL2 is associated with poor prognosis in patients with ovarian cancer. Med (Baltim). 2021;100:e24125.","journal-title":"Med (Baltim)"},{"key":"3765_CR96","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.12659\/MSM.909205","volume":"24","author":"D Zhou","year":"2018","unstructured":"Zhou D, Li Z, Bai X. BRAF V600E and RET\/PTC promote the activity of nuclear Factor-\u03baB, inflammatory mediators, and lymph node metastasis in papillary thyroid carcinoma: A study of 50 patients in inner Mongolia. Med Sci Monit. 2018;24:6795\u2013808.","journal-title":"Med Sci Monit"},{"key":"3765_CR97","doi-asserted-by":"crossref","unstructured":"Urbantat RM, Blank A, Kremenetskaia I, Vajkoczy P, Acker G, Brandenburg S. The CXCL2\/IL8\/CXCR2 pathway is relevant for brain tumor malignancy and endothelial cell function. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22052634"},{"key":"3765_CR98","doi-asserted-by":"publisher","first-page":"BSR20204312","DOI":"10.1042\/BSR20204312","volume":"41","author":"T Lin","year":"2021","unstructured":"Lin T, Zhang E, Mai P, Zhang Y, Chen X, Peng L. CXCL2\/10\/12\/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma. Biosci Rep. 2021;41:BSR20204312.","journal-title":"Biosci Rep"},{"key":"3765_CR99","doi-asserted-by":"publisher","first-page":"e5837","DOI":"10.1002\/bmc.5837","volume":"38","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhong Z, Deng Y, Lu Y, Qin X. M2 tumor\u2013associated macrophages and CXCL2 induce lipid remodeling in hepatocellular carcinoma cell lines. Biomed Chromatogr. 2024;38:e5837.","journal-title":"Biomed Chromatogr"},{"key":"3765_CR100","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.omto.2020.12.011","volume":"20","author":"YC Pan","year":"2021","unstructured":"Pan YC, Nishikawa T, Chang CY, Tai JA, Kaneda Y. CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy. Mol Therapy - Oncolytics. 2021;20:175\u201386.","journal-title":"Mol Therapy - Oncolytics"},{"key":"3765_CR101","doi-asserted-by":"publisher","first-page":"6107865","DOI":"10.1155\/2020\/6107865","volume":"2020","author":"K Liu","year":"2020","unstructured":"Liu K, Lai M, Wang S, Zheng K, Xie S, Wang X. Construction of a CXC Chemokine-Based prediction model for the prognosis of colon cancer. Biomed Res Int. 2020;2020:6107865.","journal-title":"Biomed Res Int"},{"key":"3765_CR102","doi-asserted-by":"publisher","first-page":"11822","DOI":"10.1002\/jcp.27891","volume":"234","author":"M-C Chen","year":"2019","unstructured":"Chen M-C, Baskaran R, Lee N-H, Hsu H-H, Ho T-J, Tu C-C, et al. CXCL2\/CXCR2 axis induces cancer stem cell characteristics in CPT-11-resistant LoVo colon cancer cells via G\u03b1i-2 and G\u03b1q\/11. J Cell Physiol. 2019;234:11822\u201334.","journal-title":"J Cell Physiol"},{"key":"3765_CR103","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3892\/or.2017.5453","volume":"37","author":"T Shen","year":"2017","unstructured":"Shen T, Yang Z, Cheng X, Xiao Y, Yu K, Cai X, et al. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K\/Akt\/NF-\u03baB signaling pathway. Oncol Rep. 2017;37:2095\u2013100.","journal-title":"Oncol Rep"},{"key":"3765_CR104","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s41388-018-0533-4","volume":"38","author":"M Shimizu","year":"2019","unstructured":"Shimizu M, Tanaka N. IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells. Oncogene. 2019;38:1520\u201333.","journal-title":"Oncogene"},{"key":"3765_CR105","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/ar.22521","volume":"295","author":"Z Xu","year":"2012","unstructured":"Xu Z, Wu R. Alteration in metastasis potential and gene expression in human lung cancer cell lines by ITGB8 Silencing. Anat Rec (Hoboken). 2012;295:1446\u201354.","journal-title":"Anat Rec (Hoboken)"},{"key":"3765_CR106","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.180.8.5699","volume":"180","author":"SK Raghuwanshi","year":"2008","unstructured":"Raghuwanshi SK, Nasser MW, Chen X, Strieter RM, Richardson RM. Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J Immunol. 2008;180:5699\u2013706.","journal-title":"J Immunol"},{"key":"3765_CR107","doi-asserted-by":"publisher","first-page":"113751","DOI":"10.1016\/j.celrep.2024.113751","volume":"43","author":"C Deng","year":"2024","unstructured":"Deng C, Xu Y, Chen H, Zhu X, Huang L, Chen Z, et al. Expression pattern and prognostic significance of chemokines in breast cancer: an integrated bioinformatics analysis. Cell Rep. 2024;43:113751.","journal-title":"Cell Rep"},{"key":"3765_CR108","doi-asserted-by":"publisher","first-page":"e70960","DOI":"10.1371\/journal.pone.0070960","volume":"8","author":"G Rong","year":"2013","unstructured":"Rong G, Kang H, Wang Y, Hai T, Sun H. Candidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs). PLoS ONE. 2013;8:e70960.","journal-title":"PLoS ONE"},{"key":"3765_CR109","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbi.2023.02.004","volume":"109","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Sang R, Bao J, Jiang Z, Qian D, Zhou Y, et al. Schwann cell-derived CXCL2 contributes to cancer pain by modulating macrophage infiltration in a mouse breast cancer model. Brain Behav Immun. 2023;109:308\u201320.","journal-title":"Brain Behav Immun"},{"key":"3765_CR110","doi-asserted-by":"crossref","unstructured":"Lin T, Zhang E, Mai P-P, Zhang Y-Z, Chen X, Peng L-S. CXCL2\/10\/12\/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma. Biosci Rep. 2021;41.","DOI":"10.1042\/BSR20204312"},{"key":"3765_CR111","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3934\/mbe.2020070","volume":"17","author":"YH Wang","year":"2019","unstructured":"Wang YH, Huang JH, Tian ZF, Zhou YF, Yang J. The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma. Math Biosci Eng. 2019;17:1381\u201395.","journal-title":"Math Biosci Eng"},{"key":"3765_CR112","doi-asserted-by":"publisher","first-page":"1385559","DOI":"10.3389\/fgene.2024.1385559","volume":"15","author":"X Ma","year":"2024","unstructured":"Ma X, Cui M, Guo Y. Bioinformatics analysis of the association between obesity and gastric cancer. Front Genet. 2024;15:1385559.","journal-title":"Front Genet"},{"key":"3765_CR113","first-page":"427","volume":"454","author":"U Weiss","year":"2008","unstructured":"Weiss U. Inflamm Nat. 2008;454:427.","journal-title":"Inflamm Nat"},{"key":"3765_CR114","doi-asserted-by":"publisher","first-page":"15222","DOI":"10.1038\/s41598-018-33660-z","volume":"8","author":"J-R Noh","year":"2018","unstructured":"Noh J-R, Kim Y-H, Kim D-K, Hwang JH, Kim K-S, Choi D-H, et al. Small heterodimer partner negatively regulates C-X-C motif chemokine ligand 2 in hepatocytes during liver inflammation. Sci Rep. 2018;8:15222.","journal-title":"Sci Rep"},{"key":"3765_CR115","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cell.2020.08.020","volume":"183","author":"AS Neupane","year":"2020","unstructured":"Neupane AS, Willson M, Chojnacki AK, Vargas E, Silva Castanheira F, Morehouse C, Carestia A, et al. Patrolling alveolar macrophages conceal bacteria from the immune system to maintain homeostasis. Cell. 2020;183:110\u2013e12511.","journal-title":"Cell"},{"key":"3765_CR116","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/infdis\/173.1.159","volume":"173","author":"MJ Greenberger","year":"1996","unstructured":"Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL, McGillicuddy DC, et al. Neutralization of macrophage inflammatory Protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis. 1996;173:159\u201365.","journal-title":"J Infect Dis"},{"key":"3765_CR117","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2249.2010.04231.x","volume":"162","author":"PM Fitch","year":"2010","unstructured":"Fitch PM, Wheelhouse NM, Bowles P, Paterson M, Longbottom D, Entrican G, et al. Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2\/CXCL2 expression. Clin Exp Immunol. 2010;162:372\u20138.","journal-title":"Clin Exp Immunol"},{"key":"3765_CR118","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(04)16867-0","volume":"364","author":"K Hiramatsu","year":"2004","unstructured":"Hiramatsu K, Cui L, Kuwahara-Arai K. Has vancomycin-resistant Staphylococcus aureus started going it alone? Lancet. 2004;364:565\u20136.","journal-title":"Lancet"},{"key":"3765_CR119","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/nu12040926","volume":"12","author":"S-H Kim","year":"2020","unstructured":"Kim S-H, Hong J-H, Yang W-K, Geum J-H, Kim H-R, Choi S-Y, et al. Herbal combinational medication of glycyrrhiza glabra, agastache rugosa containing glycyrrhizic acid, Tilianin inhibits neutrophilic lung inflammation by affecting CXCL2, Interleukin-17\/STAT3 signal pathways in a murine model of COPD. Nutrients. 2020;12:926.","journal-title":"Nutrients"},{"key":"3765_CR120","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3390\/nu11092023","volume":"11","author":"K Kojima","year":"2019","unstructured":"Kojima K, Asai K, Kubo H, Sugitani A, Kyomoto Y, Okamoto A, et al. Isoflavone aglycones attenuate cigarette Smoke-Induced emphysema via suppression of neutrophilic inflammation in a COPD murine model. Nutrients. 2019;11:2023.","journal-title":"Nutrients"},{"key":"3765_CR121","doi-asserted-by":"publisher","first-page":"e132836","DOI":"10.1172\/jci.insight.132836","volume":"5","author":"S Ouyang","year":"2020","unstructured":"Ouyang S, Liu C, Xiao J, Chen X, Lui AC, Li X. Targeting IL-17A\/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases. JCI Insight. 2020;5:e132836.","journal-title":"JCI Insight"},{"key":"3765_CR122","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cei.13527","volume":"203","author":"X Wang","year":"2021","unstructured":"Wang X, Sun L, He N, An Z, Yu R, Li C, et al. Increased expression of CXCL2 in ACPA-positive rheumatoid arthritis and its role in osteoclastogenesis. Clin Exp Immunol. 2021;203:194\u2013208.","journal-title":"Clin Exp Immunol"},{"key":"3765_CR123","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/art.42124","volume":"74","author":"CT Nguyen","year":"2022","unstructured":"Nguyen CT, Furuya H, Das D, Marusina AI, Merleev AA, Ravindran R, et al. Peripheral \u0393\u03b4 T cells regulate neutrophil expansion and recruitment in experimental psoriatic arthritis. Arthritis Rheumatol. 2022;74:1524\u201334.","journal-title":"Arthritis Rheumatol"},{"key":"3765_CR124","doi-asserted-by":"publisher","first-page":"579475","DOI":"10.3389\/fimmu.2020.579475","volume":"11","author":"J Volzke","year":"2020","unstructured":"Volzke J, Schultz D, Kordt M, M\u00fcller M, Bergmann W, Methling K, et al. Inflammatory joint disease is a risk factor for Streptococcal sepsis and septic arthritis in mice. Front Immunol. 2020;11:579475.","journal-title":"Front Immunol"},{"key":"3765_CR125","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019. J Am Coll Cardiol. 2020;76:2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"3765_CR126","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1172\/JCI67604","volume":"123","author":"A Dorhoi","year":"2013","unstructured":"Dorhoi A, Iannaccone M, Farinacci M, Fa\u00e9 KC, Schreiber J, Moura-Alves P, et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J Clin Invest. 2013;123:4836\u201348.","journal-title":"J Clin Invest"},{"key":"3765_CR127","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.aaa8064","volume":"349","author":"A Warnatsch","year":"2015","unstructured":"Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349:316\u201320.","journal-title":"Science"},{"key":"3765_CR128","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/ijo.2016.26","volume":"40","author":"V Rainone","year":"2016","unstructured":"Rainone V, Schneider L, Saulle I, Ricci C, Biasin M, Al-Daghri NM, et al. Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents. Int J Obes. 2016;40:1026\u201333.","journal-title":"Int J Obes"},{"key":"3765_CR129","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.2337\/diabetes.52.11.2821","volume":"52","author":"I Goren","year":"2003","unstructured":"Goren I, K\u00e4mpfer H, Podda M, Pfeilschifter J, Frank S. Leptin and wound inflammation in diabetic Ob\/ob mice. Diabetes. 2003;52:2821\u201332.","journal-title":"Diabetes"},{"key":"3765_CR130","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1523-1747.2000.00029.x","volume":"115","author":"C Wetzler","year":"2000","unstructured":"Wetzler C, K\u00e4mpfer H, Stallmeyer B, Pfeilschifter J, Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatology. 2000;115:245\u201353.","journal-title":"J Invest Dermatology"},{"key":"3765_CR131","doi-asserted-by":"crossref","unstructured":"Siebert A, Goren I, Pfeilschifter J, Frank S. Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation. Sethi JK, editor. PLoS ONE. 2016;11:e0168562.","DOI":"10.1371\/journal.pone.0168562"},{"key":"3765_CR132","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1161\/ATVBAHA.114.303585","volume":"34","author":"P Stachon","year":"2014","unstructured":"Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, et al. P2Y 6 deficiency limits vascular inflammation and atherosclerosis in mice. ATVB. 2014;34:2237\u201345.","journal-title":"ATVB"},{"key":"3765_CR133","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/sj.jid.5700842","volume":"127","author":"I Goren","year":"2007","unstructured":"Goren I, M\u00fcller E, Schiefelbein D, Christen U, Pfeilschifter J, M\u00fchl H, et al. Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in Ob\/ob mice by inactivation of macrophages. J Invest Dermatol. 2007;127:2259\u201367.","journal-title":"J Invest Dermatol"},{"key":"3765_CR134","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1089\/ars.2011.4487","volume":"18","author":"F Montecucco","year":"2013","unstructured":"Montecucco F, Bauer I, Braunersreuther V, Bruzzone S, Akhmedov A, L\u00fcscher TF, et al. Inhibition of nicotinamide phosphoribosyltransferase reduces Neutrophil-Mediated injury in myocardial infarction. Antioxid Redox Signal. 2013;18:630\u201341.","journal-title":"Antioxid Redox Signal"},{"key":"3765_CR135","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1161\/01.CIR.0000148824.93600.F3","volume":"110","author":"YNA Nabah","year":"2004","unstructured":"Nabah YNA, Mateo T, Estell\u00e9s R, Mata M, Zagorski J, Sarau H, et al. Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines. Circulation. 2004;110:3581\u20136.","journal-title":"Circulation"},{"key":"3765_CR136","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","volume":"72","author":"C Conche","year":"2023","unstructured":"Conche C, Finkelmeier F, Pe\u0161i\u0107 M, Nicolas AM, B\u00f6ttger TW, Kennel KB, et al. Combining ferroptosis induction with MDSC Blockade renders primary tumours and metastases in liver sensitive to immune checkpoint Blockade. Gut. 2023;72:1774\u201382.","journal-title":"Gut"},{"key":"3765_CR137","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pupt.2015.02.001","volume":"31","author":"AM Kirsten","year":"2015","unstructured":"Kirsten AM, F\u00f6rster K, Radeczky E, Linnhoff A, Balint B, Watz H, et al. The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD. Pulm Pharmacol Ther. 2015;31:36\u201341.","journal-title":"Pulm Pharmacol Ther"},{"key":"3765_CR138","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1183\/13993003.00148-2015","volume":"46","author":"A De Soyza","year":"2015","unstructured":"De Soyza A, Pavord I, Elborn JS, Smith D, Wray H, Puu M, et al. A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis. Eur Respir J. 2015;46:1021\u201332.","journal-title":"Eur Respir J"},{"key":"3765_CR139","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-021-01355-1","volume":"20","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Mo F, Li Q, Han X, Shi H, Chen S, et al. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin. Mol Cancer. 2021;20:62.","journal-title":"Mol Cancer"},{"key":"3765_CR140","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri2742","volume":"10","author":"W Zou","year":"2010","unstructured":"Zou W, Restifo NP. T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol. 2010;10:248\u201356.","journal-title":"Nat Rev Immunol"},{"key":"3765_CR141","doi-asserted-by":"publisher","first-page":"2400370","DOI":"10.1002\/advs.202400370","volume":"11","author":"AS La\u2019ah","year":"2024","unstructured":"La\u2019ah AS, Tsai P, Yarmishyn AA, Ching L, Chen C, Chien Y, et al. Neutrophils recruited by NKX2-1 suppression via activation of CXCLs\/CXCR2 axis promote lung adenocarcinoma progression. Adv Sci. 2024;11:2400370.","journal-title":"Adv Sci"},{"key":"3765_CR142","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Sig Transduct Target Ther. 2021;6:263.","journal-title":"Sig Transduct Target Ther"},{"key":"3765_CR143","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/978-3-0348-0837-8_17","volume":"816","author":"GB Maru","year":"2014","unstructured":"Maru GB, Gandhi K, Ramchandani A, Kumar G. The role of inflammation in skin cancer. Adv Exp Med Biol. 2014;816:437\u201369.","journal-title":"Adv Exp Med Biol"},{"key":"3765_CR144","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03765-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:00:51Z","timestamp":1744203651000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03765-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":144,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3765"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03765-3","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"1 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}